Transcutaneous pO2 measurement during tourniquet-induced venous occlusion using dynamic phosphorescence imaging

A sufficient oxygen supply in skin grafts requires a functioning microcirculation. Venous occlusion impairs the microcirculation and is therefore a major threat of healing. Luminescence life time imaging (LLI) enables the non-invasive and two-dimensional assessment of the transcutaneous oxygen partial pressure (p(tc)O2). In the current trial this new device was applied for monitoring of venous congestion. A tourniquet on the upper arm was inflated up to 40-50 mmHg and released after 10 min in eight healthy volunteers. The p(tc)O2 was measured at the lower arm every minute prior to, during and up to 10 min after cuff occlusion (40 degrees C applied skin temperature) using LLI of platinum(II)-octaethyl-porphyrin immobilized in a polystyrene matrix. For validation the polarographic Clark electrode technique was applied in close proximity and measurement was performed simultaneously. p(tc)O2 measurements prior to (Clark: 50.68+/-5.69 mmHg vs. LLI: 50.89+/-4.96 mmHg) and at the end of the venous congestion (Clark: 16.41+/-4.54 mmHg vs. LLI: 23.82+/-3.23 mmHg) did not differ significantly using the Clark electrode vs. LLI. At the initial congestion respectively reperfusion phase the Clark electrode measured faster decreases respectively increase of p(tc)O2 due to oxygen consumption of this method. This experimental trial demonstrates the applicability of LLI to quantify the p(tc)O2 under changing venous blood flow. The use of planar transparent sensors allows the non-invasive generation of two-dimensional maps of surface pO2 what makes this method particular suitable for monitoring of skin grafts.

Observational study of perioperative P tc co2 and S p o2 in non-ventilated patients receiving epidural infusion or patient-controlled analgesia using a single earlobe monitor (TOSCA) †

BACKGROUND

TOSCA, a non-invasive monitor with a single earlobe probe incorporating a Stow-Severinghaus electrode and optical sensor (Linde Medical Sensors AG, Basel, Switzerland), has previously been used with ventilated patients and in sleep laboratories. We recorded transcutaneous carbon dioxide pressures (Ptc(co(2)) and oxygen saturations (Sp(o(2)) in non-ventilated patients to investigate opioid-induced respiratory depression.

METHODS

This observational cohort study included 28 ASA I and II patients, monitored between 10 p.m. and 6 a.m., before and after elective major laparotomy. After operation, patients were kept on oxygen, 4 litre min(-1), and received either bupivacaine (0.1%) containing fentanyl (2 microg ml(-1) via epidural catheter (epidural analgesia group, EPI; n = 14) or morphine via patient-controlled analgesia infusion pump (PCA-morphine group, PCA; n = 14).

RESULTS

The preoperative median (lower/upper quartile) Ptc(co(2)) was similar in both groups at around 5.5 kPa, but significantly higher after operation in PCA with 6.9 kPa (5.6/7.3) (P = 0.02), accompanied by a longer hypercarbia time >6 kPa of 6.6 h (0.1/8.0) (P = 0.04), and lower respiratory rates of 13.9 breaths min(-1) (13.3/15.4) (P = 0.04). In EPI, the corresponding results were 5.8 kPa (5.5/6.0), 1.2 h (0.1/4.3), and 16.2 breaths min(-1) (14.8/16.7). The perioperative median Sp(o(2)) in both groups was comparable within the normal range, although generally higher when on supplemental oxygen (P = 0.26). The Sp(o(2)) time <94% was similar in both groups (P = 0.33) as were pain scores (P = 0.25).

CONCLUSIONS

Ptc(co(2)) recording in patients on PCA-morphine and supplemental oxygen revealed hypercapnia in the presence of normal respiratory rates and Sp(o(2)) values. This is recommended as an easy and sensitive monitor of respiratory depression and may have a role in the safe administration of opioid-analgesia.

Clinical Validation of a Digital Transcutaneous PCO2/SpO2 Ear Sensor in Adult Patients after Cardiac Surgery

OBJECTIVE

The aim of this study was to validate the V-Sign digital sensor (SenTec AG, Therweil, Switzerland) for combined noninvasive assessment of pulse oxymetric oxygen saturation (SpO(2)) and transcutaneous carbon dioxide tension (PtcCO(2)) in adults after cardiac surgery.

METHODS

In twenty one patients, aged 51-86 years, simultaneous measurements of blood gases with the V-Sign Sensor and with two Nellcor Durasensors (model DS-100A), one at the opposite earlobe and one with a finger clip, were compared first during hyper-, normo- and hypocapnia and at different pulse rates using a pacemaker, and then at 2-h intervals up to 8 h. Agreement was assessed by Bland-Altman analysis.

RESULTS

PtcCO(2) data of three patients were excluded because of calibration failure of the device. Median (range) PtcCO(2) for the remaining patients was 5.49 (3.3-7.6) kPa and arterial carbon dioxide tension (PaCO(2)) was 5.43 (3.61-7.41) kPa. Corresponding mean bias was +0.05 kPa and limits of agreement (LOA) were -1.2/+1.3 kPa. During normo- and hypoventilation, mean bias was good at +0.02 and +0.04 kPa respectively, but limits of agreement were poor at -0.67/+0.69 and -0.81/+0.88 kPa. In 10 patients, an initial overshoot of PtcCO(2 )was observed. Mean bias of SpO(2) and pulse rate was close to zero (-1.5% and +0.001 bpm respectively), but limits of agreement were unacceptably high (-21.4/+18.4% and -22.3/+22.3 bpm).

CONCLUSIONS

In the present state of development the SenTeC Digital monitor V-Sign device has serious limitations. Additional efforts are necessary to eliminate calibration failures and the initial overshoot of PtcCO(2) as well as to improve detection of SpO(2) and pulse rate.

End tidal carbon dioxide monitoring in prehospital and retrieval medicine: a review

End tidal carbon dioxide (ETCO2) monitoring is the non-invasive measurement of exhaled CO2. The Intensive Care Society guidelines include (ETCO2) monitoring as one of the objective standards required for monitoring patients in transport, and the American Heart Association recommends that all intubations must be confirmed by some form of ETCO2 measurement. The physiological principles and technology underlying ETCO2 measurement and the clinical indication for its use in the prehospital environment are reviewed. ETCO2 monitoring has been widely established in the prehospital environment and is of particular use for verification of endotracheal tube placement. It is non-invasive and easy to apply to breathing circuits. The units now available are compact and rugged, with extended battery operating times, which are ideally suited for prehospital use and should be considered as an essential item for advanced airway management.

The accuracy of non-invasive carbon dioxide monitoring: a clinical evaluation of two transcutaneous systems

We determined the accuracy of two transcutaneous carbon dioxide monitoring systems (SenTec Digital Monitor with V-Sign Sensor and TOSCA 500 with TOSCA Sensor 92) for the measurement of single values and trends in the arterial partial pressure of carbon dioxide in 122 adult patients during major surgery and in 50 adult patients in the intensive care unit. One or several paired measurements were performed in each patient. The first measurement was used to determine the accuracy of a single value of transcutaneous carbon dioxide; the difference between the first and the last measurements was used to analyse the accuracy and to track trends. We defined a 95% limit of agreement of <or=1 kPa as being clinically useful. There was insufficient agreement between transcutaneous carbon dioxide partial pressure values derived from the two systems and arterial carbon dioxide values for both single values and trends as defined by our suggested limit of agreement. We conclude that these systems cannot replace conventional blood gas analysis in the clinical setting studied.

Evaluation of a combined transcutaneous carbon dioxide pressure and pulse oximetry sensor in adult sheep and dogs

OBJECTIVE

To evaluate a combined transcutaneous carbon dioxide pressure (tcPCO(2)) and pulse oximetry sensor in sheep and dogs.

ANIMALS

13 adult sheep and 11 adult dogs.

PROCEDURES

During inhalation anesthesia, for the first 10 minutes following sensor placement, arterial blood gas was analyzed and tcPCO(2) was recorded every 2 minutes. Subsequently, the animals were hyper-, normo-, and hypoventilated. The simultaneously obtained tcPCO(2) and PaCO(2) values were analyzed by use of Bland-Altman statistical analysis.

RESULTS

Mean +/- SD overall difference between tcPCO(2) and PaCO(2) 10 minutes after sensor application was 13.3 +/- 8.4 mm Hg in sheep and 8.9 +/- 12 mm Hg in dogs. During hyper-, normo-, and hypoventilation, mean difference (bias) and precision (limits of agreement [bias +/- 2 SD]) between tcPCO(2) and PaCO(2) values were 13.2 +/- 10.4 mm Hg (limits of agreement, -7.1 and 33.5 mm Hg) in sheep and 10.6 +/- 10.5 mm Hg (limits of agreement, -9.9 and 31.2 mm Hg) in dogs, respectively. Changes in PaCO(2) induced by different ventilation settings were detected by the tcPCO(2) sensor with a lag (response) time of 4.9 +/- 3.5 minutes for sheep and 6.2 +/- 3.6 minutes for dogs.

CONCLUSIONS AND CLINICAL RELEVANCE

The tcPCO(2) sensor overestimated PaCO(2) in sheep and dogs and followed changes in PaCO(2) with a considerable lag time. The tcPCO(2) sensor might be useful for noninvasive monitoring of changes but cannot be used as a surrogate measure for PaCO(2).

Long-range correlated glucose fluctuations in diabetes

OBJECTIVES

Our objective is to investigate diabetes-related alteration of glucose control in diurnal fluctuations in normal daily life by detrended fluctuation analysis (DFA).

METHODS

The fluctuations of glucose of 12 non-diabetic subjects and 15 diabetic patients were measured using a continuous glucose monitoring system (CGMS) over a period of one day. The glucose data was calculated by the DFA method, which is capable of revealing the presence of long-range correlations in time series with inherent non-stationarity.

RESULTS

Compared with the non-diabetic subjects, the mean glucose level and the standard deviation are significantly higher in the diabetic group. The DFA exponent alpha is calculated, and glucose time series are searched for the presence of negatively (0.5 < alpha < 1.5) or positively (1.5 < alpha) correlated fluctuations. A crossover phenomenon, i.e. a change in the level of correlations, is observed in the non-diabetic subjects at about two hours; the net effects of glucose flux/reflux causing temporal changes in glucose concentration are negatively correlated in a "long-range" (> two hours) regime. However, for diabetic patients, the DFA exponent alpha = 1.65 +/- 0.30, and in the same regime positively correlated fluctuations are observed, suggesting that the net effects of the flux and reflux persist for many hours.

CONCLUSIONS

Such long-range positive correlation in glucose homeostasis may reflect pathogenic mechanisms of diabetes, i.e., the lack of the tight control in blood glucose regulation. Using modern time series analysis methods such as DFA, continuous evaluation of glucose dynamics could promote better diagnoses and prognoses of diabetes and a better understanding of the fundamental mechanism of glucose dysregulation in diabetes.

Comparison of the transcutaneous oxygen and carbon dioxide tension in different electrode locations during general anaesthesia

BACKGROUND AND OBJECTIVE

The best place for the electrode of transcutaneous measurement of oxygen tension (tcPO2) and carbon dioxide tension (tcPCO2) during general anaesthesia was investigated in three different locations.

METHODS

Fifteen patients for major abdominal surgery in the supine position were studied. The electrode of the TCM4 (Radiometer, Copenhagen, Denmark) was put on the chest, upper arm or forearm. TcPO2, tcPCO2, end-tidal carbon dioxide tension (etCO2), percutaneous oxygen saturation (SaO2), arterial oxygen tension (PaO2 ) and arterial carbon dioxide tension (PaCO2) were simultaneously measured at four different etCO2 concentrations and inhaled oxygen percentages and the location of the electrode was changed to other places to repeat the same measurement. In total, 12 measurements for each patient and 60 measurements for each place were performed.

RESULTS

TcPO2 correlated better than SaO2 (R2 = 0.58) with PaO2 (R2 = 0.76), and tcPCO2 correlated well with PaCO2 (R2 = 0.76) and etCO2 (R2 = 0.74) when the electrode was put on the chest, while not on the upper arm or forearm (R2 < 0.5). However, limits of agreement were too big to use tcPO2 (bias, -67.9; limits of agreement, 16.5, -152.3) and tcPCO2 (bias, -0.47; limits of agreement, 8.7, -9.64) as surrogate measures of PaO2 and PaCO2, respectively even when the electrode was put on the chest.

CONCLUSIONS

When the electrode was put on the chest, tcPO2 and tcPCO2 might be available as non-invasive monitors of oxygenation and CO2 status during general anaesthesia, while the absolute values were not interchangeable with PaO2 and PaCO2, respectively.

Continuous monitoring of central venous oxygen saturation in neonates and small infants: in vitro evaluation of two different oximetry catheters

BACKGROUND

Accurate assessment and monitoring of the cardiocirculatory function are essential during major pediatric and pediatric cardiac surgery. Monitoring of the central venous oxygen saturation (ScvO(2)) may be a better indicator of tissue oxygenation and derangement of cellular oxygen utilization than the more commonly used vital parameters. Therefore, we compared oxygen saturation measurements with thin fiberoptic oximetry catheters and standard blood gas oximetry in an in vitro setting.

METHODS

Two different size continuous fiberoptic oximetry catheters (2-4-F) were inserted in an extracorporeal circuit filled with human red blood cells in normal saline (haematocrit 30%, flow 600 ml.min(-1)). The results of fiberoptic oximetry were then compared with standard blood gas oximetry for a wide range of different oxygen saturations using linear regression.

RESULTS

The oxygen saturations found ranged from 9% to 100%. The results of the two different fiberoptic oximetry catheters correlated significantly (r = 0.99, P < 0.0001) with standard blood gas oximetry.

CONCLUSION

The results of fiberoptic oximetry are nearly identical with standard blood gas oximetry for a wide range of different oxygen saturations. Thin oximetry catheters can be inserted percutaneously even in neonates and small infants. The continuous monitoring of ScvO(2) may be beneficial, especially in patients who are in danger of developing low cardiac output or sudden cardiovascular collapse.

Effects of the electrode temperature of a new monitor, TCM4, on the measurement of transcutaneous oxygen and carbon dioxide tension

The transcutaneous measurement of oxygen (tcP(O2)) and carbon dioxide (tcP(CO2)) tensions may serve as a surrogate of arterial oxygen (Pa(O2)) and carbon dioxide (Pa(CO2)) tensions, respectively. We investigated the effects of the electrode temperature of a new device, TCM4, on the measurement of tcP(O2) and tcP(CO2). Twenty-five patients scheduled for major lower abdominal surgery were enrolled. The electrode of the TCM4 was attached to the chest, with its temperature set to 37 degrees C, 40 degrees C, 42 degrees C, 43 degrees C, or 44 degrees C. tcP(O2), tcP(CO2), end-tidal carbon dioxide tension (Et(CO2)), Pa(O2), and Pa(CO2) were simultaneously measured at various Et(CO2) levels and inhaled oxygen concentrations. The times required for stabilization of the tcP(O2) and tcP(CO2) values were measured. A Bland-Altman plot was used to compare the two measurements. The time required for stabilization was shorter with a higher electrode temperature, but the shortest time was still more than 150 s. TcP(O2) correlated well with Pa(O2) at 43 degrees C and 44 degrees C. TcP(CO2) correlated well with Pa(CO2) and Et(CO2) at 43 degrees C. The bias and limits of agreement were larger with lower electrode temperature for TcP(O2)--Pa(O2), tcP(CO2)--Pa(CO2), and tcP(CO2)-Et(CO2). We concluded that the electrode of the TCM4 should be heated to at least 43 degrees C to measure tcP(O2) and tcP(CO2). However, the absolute values of tcP(O2) and tcP(CO2) could not be used as surrogate measurements of Pa(O2) and Pa(CO2), respectively.

[Transcutaneous measurement of partial pressure of carbon dioxide and oxygen saturation: validation of the SenTec monitor]

OBJECTIVE

To validate a monitor for transcutaneous measurement of oxygen saturation (SpO2) and partial pressure of carbon dioxide (TcPCO2).

PATIENTS AND METHODS

This observational study included 140 Caucasian nonsmokers without jaundice. Patients underwent forced spirometry, measurement of SpO2 and TcPCO2 with the SenTec monitor, and arterial blood gas analysis (readings with 2 devices) during the stabilization phase of the monitor. In the statistical analysis, values from the 2 devices for measuring arterial blood gases were compared by mean differences for PaCO2 and oxygen saturation (SaO2). The arithmetic mean of the 2 blood gas measurements was calculated and relations between them and the SpO2 and TcPCO2 were assessed by the Pearson correlation coefficient (r) and the intraclass correlation coefficient (ICC) as a measure of agreement. Bland-Altman analysis was used to test data dispersion.

RESULTS

Ten patients were excluded due to a systematic error in the gas calibrator. The mean (SD) time to stabilization of the monitor before reading was 13.9 (2.4) minutes. The forced expiratory volume in the first second was greater than 80% in 40 patients, between 60% and 79% in 23, between 40% and 59% in 30, and less than 40% in 37. The mean (SD) differences between arterial blood gas measurements were 0.28 (1.0) mm Hg for PaCO2, -0.06% (0.86%) for SaO2, and -0.9 (2.7) mm Hg for PaO2. In the tests for correlation and agreement, r was 0.74 and ICC was 0.73 for SaO2 and SpO2; r was 0.92 and ICC was 0.92 for PaCO2 and TcPCO2. The subgroup analyses did not show any noteworthy differences. The Bland Altman analysis showed no significant dispersion. It was observed that the SenTec monitor underestimated oxygen saturation values by around 1% with respect to SaO2 and overestimated carbon dioxide pressure by 1 mm Hg with respect to PaCO2 values.

CONCLUSIONS

The stabilization time recommended for the SenTec monitor before taking a reading is 20 minutes. The overestimates and underestimates by the monitor are not clinically relevant. Finally, the values for SpO2 and TcPCO2 measured by the validated monitor are reliable.

[Method of evading the overshoot phenomenon of transcutaneous P(CO2) measurement at the ear lobe]

BACKGROUND

Kagawa et al. confirmed the overshoot of transcutaneous P(CO2) (Ptc(CO2)) during the early stage of measurement with Ptc(CO2) monitor (TOSCA, Linde Medical Sensors AG, Basel, Switzerland). We examined the method to evade this phenomenon.

METHODS

Eight adult patients under general anesthesia were examined. Two probes were mounted each on the left and right ear lobes after constant end expiratory P(CO2) had been obtained for ten to fifteen minutes. One P(CO2) probe was set at 42 degrees C. Another one was set at 45 degrees C for the first 15 minutes and then decreased to 42 degrees C.

RESULTS

With the probe heated at 42 degrees C, overshoot was observed in 5 out of 8 cases, the peak of which is 44 +/- 5.5 mmHg at 8.2 +/- 1.1 minutes and then these values went down to 39 +/- 4.0 mmHg at 19 +/- 1.3 minutes and stayed stable. Probes heated at 45 degrees C and placed on the opposite side did not show this phenomenon and were stabilized at 5 +/- 0.9 minutes.

CONCLUSIONS

With this apparatus, we found that it is effective to avoid overshoot to heat the probe at 45 degrees C and to change at 42 degrees C after 15 minutes.

Transcutaneous carbon dioxide monitoring

Technologies now exist that measure carbon dioxide levels transcutaneously. Rapid assessment of patients who have depressed ventilation or suspected sepsis can improve treatment decisions including the need for admission to the ICU and pulmonary artery catheterization.

Comparison of a new forehead reflectance pulse oximeter sensor with a conventional digit sensor in pediatric patients

BACKGROUND

During conditions of poor perfusion, the accuracy of conventional extremity-based pulse oximeters may be limited. Limited evidence suggests that forehead perfusion may be better preserved during such periods, but pediatric experience with newer forehead reflectance sensors is limited. We prospectively compared the accuracy of a forehead reflectance sensor, the Max-Fast, with a new-generation digit sensor in pediatric patients.

METHODS

Pediatric patients > 10 kg and who had arterial catheters were eligible for enrollment. Blood oxygen saturation was simultaneously measured with forehead and digit sensors, and compared to corresponding CO-oximetry-measured arterial oxygen saturation values (S(aO2)) taken at the same times. We used Bland-Altman analysis to calculate the bias and precision of the forehead sensor and the digit sensor relative to the S(aO2) values.

RESULTS

We obtained 116 sample sets from 28 patients. The S(aO2) values ranged from 84.1% to 99.2%. The bias and precision of the forehead-to-S(aO2) difference were 0.6% and 2.7%, respectively, versus 1.4% and 2.6%, respectively, for the digit-to-S(aO2) difference (p < 0.05). Bias and precision were 0.7% and 2.6% versus 1.7% and 2.3% for the forehead and digit sensors, respectively, (p < 0.05) in patients who received vasoactive medications, compared with 0.5% and 2.8% versus 1.1% and 2.8% (p = not significant), respectively, in patients who did not receive vasoactive medications.

CONCLUSIONS

The Max-Fast sensor estimated S(aO2) as accurately as did a new-generation digit sensor in well-perfused pediatric patients.

Validation of a new device for transcutaneous oxygen pressure recordings in real and simulated exercise tests

AIM

Measurement of transcutaneous oxygen pressure (tcpO2) is of interest in critical limb ischemia at rest and also during exercise in patients suffering proximal claudication or claudication of questionable origin. The recent commercialization of the computerized multiprobe-TCM400 device (Radiometer, Copenhagen, DK) appears attractive for exercise tests but comparison with the previous devices has not been reported. Indeed, the final endpoint for the physician is to be sure that a new apparatus will not interfere with the results observed in patients.

METHODS

Using a 5 probe-TCM400 and 5 single probe-TCM3s, simultaneous recordings of tcpO2 were performed: 1) in vitro during 25 simulated exercises and 2) in vivo during exercise treadmill tests in 27 vascular patients. We analyzed resting (REST), minimal absolute (MIN) and DROP (limb-changes minus chest-changes) values. TcpO2 absolute and DROP profiles were analyzed through cross-correlation to detect response delays between the devices.

RESULTS

In simulated tests, the Pearson coefficient of correlation between TCM400 and TCM3 was r=0.99 for REST, MIN and minimal DROP. In treadmill tests, the Pearson coefficient of correlation between TCM400 and TCM3 was significantly higher with minimal DROP (r=0.88) than with REST (r=0.63) or MIN (r=0.7). A 15 s delay was observed with TCM3 as compared to TCM400 responses for both tcpO2 and DROP profiles. The rmax(2) of the cross-correlation was 0.74 and 0.67 for tcpO2 and DROP, respectively.

CONCLUSIONS

Our observations underline the limits of the clinical in vivo comparison of 2 transcutaneous devices. Despite the differences observed in absolute values during in vivo tests with simultaneous recordings (assumed to rely on physiological and not technical problems), we suggest that TCM400 is valid for exercise tests with the advantage of improved user interface, automatic memorization and integrated multiple probes of this newly commercially available apparatus.

Biomedical sensor using thick film technology for transcutaneous oxygen measurement

Transcutaneous blood gas monitoring is a non-invasive measurement technique for obtaining fast and relatively accurate responses to determine the respiratory conditions of patients. In this investigation, a screen-printed, disposable, transcutaneous oxygen sensor based on the working principle of amperometry, incorporates an integral heating element to enhance transcutaneous diffusion of blood gases typically at 44 degrees C. A Clark cell configuration is employed with gold working and counter electrodes and a silver/silver chloride reference electrode. Two different types of electrolytes namely potassium nitrate gel and polyelectrolyte (Nafion) have been studied under laboratory test conditions. A fully computer-controlled gas testing rig has been constructed to automate the varying of oxygen levels. Linear relationships have been established with an averaged sensitivity level of 0.029 microA/mmHg. In addition, a brief pilot clinical trial involving a fully grown human subject has been carried out alongside a commercial transcutaneous blood gas analyser. The investigations have shown that although the measured signals are weaker than those obtained from the laboratory test, the thick film sensor displays a repeatable and linear relationship when correlating with the commercial system. This study has greatly contributed towards the understanding for the suitability of the materials in achieving a viable, low-cost biomedical sensor.

Rapid prototyping of pulse oximeter

Measurement of oxygen saturation levels in blood is a vital activity during most medical treatments. A pulse oximeter is a device most commonly used to perform this measurement. It provides convenient, non-invasive and continuous monitoring of oxygen levels in a human body. However, it is often a tedious task to select the appropriate hardware and software components to manufacture a pulse oximeter that gives accurate results. This paper describes a student project, which had the goals to expose the student to this important technique of applying rapid prototyping methods to the design of a state of the art pulse oximeter.

Apnea testing for the diagnosis of brain death

OBJECTIVES

A review is given on various methods, preconditions and pitfalls of apnea testing for the diagnosis of brain death.

MATERIALS AND METHODS

An extensive medical data base search was implemented by information gathered from books and our own experience with more than 2000 apnea tests.

RESULTS

While testing for apnea (AT) is considered indispensable worldwide, recommendations and handling differ. Rather than relying on elapsed time, a specific target value for the partial arterial pressure of carbon dioxide (PaCO2) should be aimed at being the maximum physiological stimulus for respiration. Methodological points are elaborated upon in detail for apneic oxygenation and hypoventilation.

CONCLUSION

AT is an indispensable element of diagnosing brain death. Although with proper handling and adequate precautions AT is safe, it should be performed as a last resort. An international agreement on target values for the PaCO2 is desirable.

Fetal pulse oximetry and neonatal outcome: a study in a developing country

BACKGROUND

The aim of this cohort, prospective study was to compare the diagnostic value of intrapartum fetal pulse oximetry (FPO) with that of fetal scalp blood gas (FSBG) for an abnormal neonatal outcome in cases with abnormal fetal heart rate (FHR) tracings.

METHODS

Fetal oxygen saturation was continuously monitored with Nellcor N-400 FPO during labor. Simultaneous FSBG determinations were obtained. The results were analyzed in relation to umbilical arterial cord blood pH and neonatal outcome. Studied FPO cutoff levels were 30 and 40% hemoglobin saturation and that of FSBG pH was 7.2.

RESULTS

During the study, there were 9825 deliveries; 415 had abnormal FHR. Only 150 fulfilled the whole screening panel. When the outcome variable was umbilical arterial pH, the positive predictive values of the three methods (FPO30, FPO40, FSBG) were 57, 61 and 65% and the negative predictive values were 43, 39 and 35% respectively. The sensitivity of FPO30 was highest (75%). Considering abnormal neonatal outcome, again the sensitivity was also highest for FPO30 (89%). The sensitivity of FSBG was 82%. The specificity of the three methods were 53, 49 and 38% respectively.

CONCLUSION

The diagnostic value of intrapartum FPO compares favorably with FSBG. FPO seems to be a reliable and less invasive tool and may decrease unnecessary interventions and unnecessary fetal scalp blood sampling in cases of suspected fetal distress. The FPO cutoff of 30% saturation defined by previous studies appears to be appropriate.

Monitoring carbon dioxide tension and arterial oxygen saturation by a single earlobe sensor in patients with critical illness or sleep apnea

OBJECTIVES

The purpose of the study was to evaluate a novel, combined sensor for transcutaneous monitoring of arterial oxygen saturation and carbon dioxide tension.

DESIGN

The new monitoring technique was compared to established reference methods.

SETTING

ICU and sleep laboratory of a university hospital.

PATIENTS

Eighteen critically ill adult patients with acute respiratory failure or heart failure, and 12 patients with sleep apnea (mean [+/- SD] apnea/hypopnea index, 43 +/- 24 events per hour).

MEASUREMENTS

Continuous measurements were performed over several hours by the novel heated (temperature, 42 degrees C) earlobe sensor (TOSCA; Linde Medical Sensors; Basel, Switzerland), incorporating electrochemical and optical elements for carbon dioxide measurement (PtcCO2) and pulse oximetry (SpO2), respectively. The data were compared to the results of repeated arterial blood gas analyses in critically ill patients and to simultaneous nocturnal pulse oximetry performed with different devices with earlobe or finger sensors in sleep apnea patients.

RESULTS

In critically ill patients, the mean difference and limits of agreement (bias +/- 2 SDs) of transcutaneous PtcCO2 vs arterial PaCO2 were 3 +/- 7 mm Hg; the corresponding values for changes in PtcCO2 vs PaCO2 were 1 +/- 6 mm Hg. The bias +/- 2 SDs for pulse oximetric SpO2 vs arterial oxygen saturation (SaO2) were 1 +/- 4%. In sleep apnea patients, the combined earlobe sensor identified more transient oxygen desaturations, and the rate of change in oxygen saturation during events was greater compared to those with other tested pulse oximeters, indicating a faster response.

CONCLUSIONS

Due to its ability to accurately assess both ventilation and oxygenation by a single transcutaneous sensor, the described noninvasive monitoring technique is a valuable tool for respiratory monitoring with potential applications in critical care and sleep medicine.

Contactless multiple wavelength photoplethysmographic imaging: a first step toward "SpO2 camera" technology

We describe a route toward contactless imaging of arterial oxygen saturation (SpO2) distribution within tissue, based upon detection of a two-dimensional matrix of spatially resolved optical plethysmographic signals at different wavelengths. As a first step toward SpO2-imaging we built a monochrome CMOS-camera with apochromatic lens and 3lambda-LED-ringlight (lambda1 = 660 nm, lambda2 = 810 nm, lambda3 = 940 nm; 100 LEDs lambda(-1)). We acquired movies at three wavelengths while simultaneously recording ECG and respiration for seven volunteers. We repeated this experiment for one volunteer at increased frame rate, additionally recording the pulse wave of a pulse oximeter. Movies were processed by dividing each image frame into discrete Regions of Interest (ROIs), averaging 10 x 10 raw pixels each. For each ROI, pulsatile variation over time was assigned to a matrix of ROI-pixel time traces with individual Fourier spectra. Photoplethysmograms correlated well with respiration reference traces at three wavelengths. Increased frame rates revealed weaker pulsations (main frequency components 0.95 and 1.9 Hz) superimposed upon respiration-correlated photoplethysmograms, which were heartbeat-related at three wavelengths. We acquired spatially resolved heartbeat-related photoplethysmograms at multiple wavelengths using a remote camera. This feasibility study shows potential for non-contact 2-D imaging reflection-mode pulse oximetry. Clinical devices, however, require further development.

Transcutaneous Pco2 monitoring in critically ill adults: Clinical evaluation of a new sensor*

OBJECTIVE

In critically ill patients, arterial blood gas analysis is the gold standard for evaluating systemic oxygenation and carbon dioxide partial pressure. A new miniaturized carbon dioxide tension Pco2-Spo2 single sensor (TOSCA, Linde Medical Sensors AG, Basel, Switzerland) continuously and noninvasively (transcutaneously) monitors both Paco2 and oxygen saturation by pulse oximetry (Spo2). The present study was designed to investigate the usability and the accuracy of this device in critically ill patients.

DESIGN

Prospective clinical investigation.

SETTING

A 20-bed, university-affiliated, surgical intensive care unit.

PATIENTS

Patients admitted after major surgery, multiple trauma, or septic shock equipped with an arterial catheter.

INTERVENTIONS

The heated (42 degrees C) sensor was fixed at the earlobe using an attachment clip. Transcutaneous Pco2 (TcPco2) measurements were correlated with Paco2 values (measured using a blood gas analyzer). In addition, the differences between Paco2 and TcPco2 values were evaluated using the method of Bland-Altman.

MEASUREMENTS AND MAIN RESULTS

We studied 55 patients, aged 18-80 (mean 57 +/- 15) yrs. A total of 417 paired measurements were compared. Correlation between TcPco2 and Paco2 was r = .86 (p < .01) in the Paco2 range of 24-101 mm Hg. Mean bias (+/-sd) between the two methods of measurement (Bland-Altman analysis) was 1.2 +/- 6.0 mm Hg with TcPco2 slightly overestimating arterial carbon dioxide tension. Nineteen percent of the measured values were outside of the acceptable clinical range of agreement of +/-7.5 mm Hg.

CONCLUSIONS

The present study suggests that Paco2 can be acceptably assessed by measuring TcPco2 using the TOSCA Pco2-Spo2 sensor.